ANAC : Analysis & Opinions

  1. Pfizer Bets Big on Eczema With Anacor Acquisition

    May 23, 2016
    Pfizer seems to have made the right bet on Anacor to capture the present day $4 billion eczema medicine market.
  2. XenoPort Stock Rises Nearly 60% on Takeover News

    May 23, 2016
    It's a fine time to be a shareholder in biotech company XenoPort (NASDAQ: XNPT). The company revealed Monday that it has ...
  3. Pfizer Buys Anacor Pharmaceuticals For $5.2B (PFE, ANAC)

    May 17, 2016
    Pfizer, which last month ended its bid for Allergan, is looking to capitalize on Anacor's experimental gel used to treat ...
  4. Pfizer to Pay 55% Premium to Acquire Anacor

    May 16, 2016
    The share price of biotech company Anacor Pharmaceuticals (NASDAQ: ANAC) rose by nearly 60% Monday following news that it ...
  5. Stocks With Bubbles That Could Burst in 2016

    January 7, 2016
    These are some of the over-valued stocks based on P/E and Forward P/E ratios. Will the bubbles burst in 2016?
  6. IWM: iShares Russell 2000 Index ETF

    December 31, 2015
    Find out more about the iShares Russell 2000 exchange-traded fund, or ETF, the characteristics of this ETF and its suitability ...
  7. Healthcare Stocks Continue to Be a Good Bet

    August 3, 2015
    Here are four stocks in the healthcare sector that have already put up big numbers, and could still go higher, if they breakout ...
  8. Consider Buying These Uptrending Stocks

    April 1, 2015
    Recent pullbacks in these uptrending stocks present an opportunity to get long for another possible rally.
  9. Investing In Biotech: Is It Worth The Risk?

    September 5, 2014
    Investors shunned biotech after a weak start in 2014. Now that a comeback is in the works, should they reconsider?
Trading Center